• Profile
Close

Developmental delay and school performance among retinoblastoma survivors: Development/school morbidity among retinoblastoma survivors

American Journal of Ophthalmology May 13, 2021

Reynolds M, Lueder G, Gordon M, et al. - Researchers conducted this retrospective cohort study to describe the academic performance of childhood retinoblastoma (RB) survivors. Seventy-three retinoblastoma patients (median age at diagnosis 9.97 months [range 0.29, 65.1]) were followed for a median of 6.4 years (0.2, 1.76). Multivariable analysis showed that a history of receiving chemotherapy was related to self-reported school difficulties, and possessing an individualized education program (IEP). The degree of visual impairment and enucleation history had no effect on the risk of self-reported school difficulties or the implementation of an IEP. Chemotherapy treatment is associated with academic difficulties in childhood RB survivors, a risk factor independent of visual acuity.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay